The Abramson Cancer Center is delighted to announce that Robert Schnoll, PhD, Associate Director for Population Science, was named John H. Glick, MD Professor in Cancer Research.
Dr. Schnoll is also the Director of the Center for Interdisciplinary Research on Nicotine Addiction, a Senior Fellow in the Penn Center for Public Health, and Co-Director of the Community Research and Engagement Core at the Penn Center for AIDS Research.
As an NIH/NCI-funded implementation scientist (P50, R01, K24) and long-standing member of the ACC Tobacco and Environmental Carcinogenesis Research Program, Dr. Schnoll’s research focuses on the study of new methods for treating nicotine dependence, the examination of novel ways to use existing treatments for nicotine dependence to improve their efficacy, and the study of methods to improve the use of smoking cessation treatments, particularly in under-served or vulnerable populations. Dr. Schnoll has conducted behavioral, physician-based, and pharmacological clinical trials for smoking cessation, and conducted tobacco control research in India and Russia. Dr. Schnoll has published more than 180 peer-reviewed publications.
Dr. Schnoll assists with the training of students, postdocs, faculty, and researchers in the US and in developing countries. He co-directed career development core facilities for NIH-funded and other extramurally-funded centers and served on advisory committees for NIH and as a member and chairperson on >80 NIH study sections. He served as an External Scientific Advisor to NCI cancer centers, the American Cancer Society, and NCI. Currently, he serves as a mentor to two dozen students, fellows, and faculty as a K24 mentoring grant recipient. He was a mentor for NCI’s Training Institute for Dissemination and Implementation Research in Cancer (TIDIRC) and Washington University’s Institute for Implementation Science Scholars. He co-chaired the Implementation Science Working Group for NCI’s Cancer Center Cessation Initiative (C3i), building collaborations and facilitating research on the use of implementation science to address tobacco use. Dr. Schnoll currently serves as a mentor for the new NIH-supported Training Institute for Dissemination and Implementation Research in Genomics and Precision Public Health (TIDIR-GPPH).
The John H. Glick, MD Professor in Cancer Research was established in 2016 when additional gifts and the growth in the value of the endowment for the John H. Glick, MD Abramson Cancer Center Director’s Professorship created funding to support an additional chair. The John H. Glick, MD Professorship in Cancer Research is awarded to a leader in scientific discovery.
Please join us in congratulating Dr. Schnoll on this honor!